Scroll To Top
Search by Speciality

The Diagnosis and Treatment of Hypoactive Sexual Desire Disorder

Grand Hyatt Washington | Washington, USA
From 450 to 550 USD
Event Preview
This event
is Finished
Title: The Diagnosis and Treatment of Hypoactive Sexual Desire Disorder
Specialty: Internal Medicine
Dates: From Nov, 30, 2018 to Nov, 30, 2018
Location: Washington, USA
Type: Course
Registration Cost: From 450 to 550 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Washington, Usa.
General Info
Event Venue:

Grand Hyatt Washington

Washington, USA Visit the Venue to read more


The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Hypoactive sexual desire disorder, or HSDD, is the most common female sexual dysfunction with about 10% of premenopausal women in the US believed to have this condition. HSDD is consistently under diagnosed, and under managed due to the lack of adequate physician-patient communication on this topic.

In this article, Dr. Mache Seibel will discuss the symptoms of HSDD, and its impact on a patient’s quality of life along with the components for a comprehensive sexual history. Also discussed will be the tools for screening and diagnosing HSDD, as well as therapeutic modalities available and processes of the FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) Program.

After participating in this educational activity, participants should be better able to:

Identify the symptoms of hypoactive sexual desire disorder

Cite barriers in their clinical practice that inhibit the appropriate diagnosis and management of HSDD

Describe the components of a comprehensive sexual history

Identify the screening tools that allow for accurate diagnosis of HSDD

Explain causal factors for HSDD and common co-morbid conditions

Identify the therapeutic modalities available to manage HSDD including their benefits and potential side effects – also including the first agent approved for this indication (flibanserin)

Identify the processes of the FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) Program that will allow healthcare providers/pharmacies to prescribe/dispense flibanserin


Mache Seibel, MD

Faculty, Department of Ob/Gyn

Beth Israel Hospital

Harvard Medical School

Boston, MA

Registration Needs updating Register Now


Registration Cost
Early Registration

Late Registration From: 2018-05-06 To: 0--
On site Registration

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Scientific Content Up to Date
Submission Info
Sponsors Exhibitors
General Info
If you are interested in sponsoring or exhibiting at one of our live meetings, please contact
Organising Agency

Omnia Education

500 Office Center Drive, Suite 300

Fort Washington, PA 19034

P: 800.889.4944

F: 215.358.0556 

Event map
Revelant Events